Evidence map›Paper›PMID 42627459›Full record

ArticleJournal of occupational rehabilitation2026

Cost-Effectiveness of IMPRovE: A Multicomponent Intervention to Increase Adherence to Guideline Recommendations for the Diagnosis and Management of Work-Related Mental Health Conditions in General Practice.

D Mortimer, V Camões-Costa, K Nolidin, S Chakraborty, J Kenardy, B Brijnath, J Enticott, M Kidd, S Reid, A Collie and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of occupational rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

D MortimerMonash Business School, Centre for Health Economics, Monash University, Building H, Caulfield Campus, Melbourne, VIC 3147, Australia. duncan.mortimer@monash.edu.
V Camões-CostaDepartment of General Practice, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
K NolidinDepartment of General Practice, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
S ChakrabortyDepartment of General Practice, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
J KenardyUniversity of Queensland, Brisbane, Australia.
B BrijnathSchool of Humanities and Social Sciences, La Trobe University, Melbourne, Australia.
J EnticottMonash Centre for Health Research and Implementation, Monash University, Melbourne, Australia.
M KiddInternational Centre for Future Health Systems, University of New South Wales, Sydney, Australia.
S ReidSpeciality of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
A CollieHealthy Working Lives Research Group, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
D MazzaDepartment of General Practice, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Funding

National Health and Medical Research Council APP1160223
6 · The paper itself

Abstract

purposeTo evaluate the cost and cost-effectiveness of a multicomponent intervention to increase general practitioners' (GPs) adherence to guideline recommendations for diagnosis and management of work-related mental health conditions (the Guideline).

methodsEconomic evaluation from Australian health system and societal perspectives based on data from a pragmatic hybrid III parallel cluster randomised controlled trial (IMPRovE) that ran from December 2020 to December 2022.

resultsThe IMPRovE intervention generated a statistically significant improvement in GP adherence scores of 0.98 on 0 to 9 scale (95%CI: 0.38 to 1.58). We found no evidence for a significant between-group difference in total quality-adjusted life days (QALDs) per patient to trial-end (adjusted mean difference: -1.9, 95%CI: -24.2 to 20.3), productivity gains per patient to trial-end (adjusted mean difference: $5,818, 95%CI: -$12,346 to $23,982), or total health sector costs per patient to trial-end (adjusted mean difference: -$2,703, 95%CI: -$6,025 to $620). Under conservative assumptions, we find a significant between-group difference in total health sector cost per GP (adjusted mean difference: -$14,278, 95%CI: -$21,358, -$7,198). For improving GP adherence to the Guideline, we can be 95% confident that the IMPRovE intervention is more cost-effective than waitlist control from a health system perspective (when we set aside productivity gains). This remains the case even when improvements in GP adherence carry zero value.

conclusionThe IMPRovE intervention is likely to be more cost-effective than waitlist control for increasing GP adherence to Guideline recommendations. We were unable to draw strong conclusions regarding the cost-effectiveness of the IMPRovE intervention for improving patient outcomes.

trial registrationACTRN12620001163998, November 2020.

Indexed as

Clinical practice guidelineCost-effectivenessEvidence-based practiceGuideline adherenceImplementation scienceWorkers’ compensationWork-related mental health

Identifiers

PMID42627459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.